http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57200379-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1981-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c247b3bab7eff298cd96066158853b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3e031c2c78c88ee6aed81c1b9b7b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa29223188087f431fd9f445a813c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc73a53703b5cdb6582ae13ea7614f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b45e663ab3ee9bb0604b862f44baa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08cc131ed8a82d49cd5d79f8e408787e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8f27821fb9224f44007b56410c4f427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1216d44ad651531644e2ea82b190b5c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a003e516b0070f4851f6e5ac45810acf
publicationDate 1982-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57200379-A
titleOfInvention Haloprostacyclins and their preparations
abstract NEW MATERIAL:A haloprostacyclin shown by the formulaI(R 1 is H or lower alkyl; R 2 and R 3 are H or protecting group; X is Cl, Br, or I or a pharmaceutically acceptable salt of its acid when R 1 is H. n EXAMPLE: 5-Bromo-Δ 6 -PGI methyl ester. n USE: A remedy or preventive for diseases resulting from thrombotic diseases. An antathmatic. An antiulcer. A hypotensor. Exhibiting an inhibiting action on blood platelet aggregation, hypotensive action, relaxing action on smooth muscle, etc. n PROCESS: A prostacyclin shown by the formula II (R 11 is lower alkyl; R 21 and R 31 are protecting group) is reacted with a halogen or halogen derivative shown by the formula XQ (Q is Cl, Br, I, group shown by the formula III, formula IV, or formula V), and, if necessary, the reaction product is deprotected and/or hydrolyzed to give a compound shown by the formulaI. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58150583-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0347272-B2
priorityDate 1981-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057777

Total number of triples: 29.